Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from FDA

Scholar Rock's Spinal Muscular Atrophy Drug Faces FDA Delay Over Catalent Indiana Inspection

The U.S. Food and Drug Administration (FDA) on Tuesday issued a Complete Response Letter (CRL) for Scholar Rock’s (NASDAQ:SRRK) apitegromab Biologics License Application (BLA) for spinal muscular atrophy (SMA).

Benzinga

The 7 Dirtiest Secrets of the Food Industry

The modern food industry is a miracle of science and logistics. It is also an industry that is filled with several shocking and often unappetizing secrets. To produce the huge amount of cheap and consistent food that we demand, the industry relies on a variety of controversial practices and ingredients.…

Grocery Coupon Guide

Trump’s inability to pronounce acetaminophen draws laughter from across the internet

‘If you can’t pronounce acetaminophen, you probably shouldn’t be giving out medical advice related to acetaminophen,’ one X user suggested

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

2 ‘Strong Buy’ Stocks That Wall Street Believes Can Soar 360% to 780%

These two growth stocks are attractive for investors seeking big upside in exchange for higher risk.

Barchart

Donald Trump claims of paracetamol link to autism should be ignored, Wes Streeting says

Health Secretary says expectant mothers should listen to doctors over US president on medical matters

Evening Standard

Trump Administration Backs Leucovorin for Autism — How It Works, the Science Behind It and Its Effectiveness

The Trump administration has backed the use of leucovorin, a folate-based drug, for autism treatment. Here's what the science says, how it works, and why experts are divided on its effectiveness.

International Business Times UK

Paracetamol, Autism and Panic: How to Read the Science Before You Change Your Pregnancy Plan

UK health bodies reaffirm paracetamol is safe in pregnancy after Trump autism claims. Experts warn misinformation could deter vital treatment.

International Business Times UK

Read news from The Economist, FT, and more,
with one subscription

White House Slammed for Tylenol-Autism Claim as Experts Insist 'It's the Vaccines' Driving Autism Fears

Experts blast Trump's Tylenol-autism claims, stressing vaccines are safe and misinformation, not paracetamol, drives autism anxiety.

International Business Times UK

Trump's Cuba, Tylenol and Autism Theory Collides with Reality: What Experts in Havana Say

President Donald Trump caused a stir when he connected autism, acetaminophen (commonly known by the brand name Tylenol in the U.S.), and the island of Cuba during a White House announcement.

Latin Times

Trump, officials link Tylenol to autism as medical community balks - Roll Call

President Trump and his health team advise against taking Tylenol during pregnancy, rebuking long-standing public health guidance.

Roll Call

More shrimp sold at Kroger stores recalled for possible radioactive contamination

A Seattle seafood distributor has recalled more cooked and frozen shrimp sold at Kroger grocery stores across the U.S. because of ongoing concerns about potential radioactive contamination

The Independent UK

FDA Clears Merck's One-Minute Cancer Shot

The U.S. Food and Drug Administration (FDA) on Friday approved Merck Co. Inc.’s (NYSE:MRK) Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph) injection for subcutaneous administration in adults across most solid tumor indications for Keytruda.

Benzinga

FDA Delays Key Sanofi Multiple Sclerosis Drug Decision

On Monday, the U.S. Food and Drug Administration (FDA) extended the review date for Sanofi SA’s (NASDAQ:SNY) new drug application (NDA) of tolebrutinib for non-relapsing, secondary progressive multiple sclerosis (nrSPMS) and to slow disability accumulation independent of relapse activity in adult patients.

Benzinga

Could This Be the Cure?

For decades, a New York writer struggled to understand why she felt so stuck. It wasn't until she tried MDMA —and finally processed a dark episode from her past—that she got her answer.

Marie Claire

Get all your
news in one place.

100’s of premium titles.
One news app.

Medical Daily

Trump to Discuss New Autism Findings After Hinting At Major Discovery During Kirk Memorial

US President Trump may address autism findings, Tylenol risks during pregnancy, and potential treatments including leucovorin in a new briefing.

Benzinga

Trump Administration To Unveil Tylenol-Autism Review, Tout This Drug As Potential Treatment: Report

The Trump administration is expected to unveil new efforts on Monday examining whether one widely used drug may be linked to autism and whether another could help treat it, according to people familiar with the plans who spoke to The Washington Post on condition of anonymity because the announcement was…

International Business Times UK

Trump Autism Update: US President Set to Discuss Autism Findings, Potential Tylenol Connection and Cure Options

US President Trump may address autism findings, Tylenol risks during pregnancy, and potential treatments including leucovorin in a new briefing.

The Independent UK

Costco recalls popular ready-to-eat item over possible listeria contamination

The affected product was sold in 32 states

Get all your
news in one place.

100’s of premium titles.
One news app.

Fortune

I used medication to overcome alcohol addiction. I've built my business on it

AA members had a lot to say about my experience with naltrexone, which is safe, effective, FDA-approved and not addictive.

Benzinga

Medtronic's New Implant Could Transform Bladder Control Treatment

Innovative medical technologies are transforming healthcare by tackling chronic conditions that affect millions, offering hope and improved quality of life. The Food and Drug Administration (FDA) approved Medtronic plc’s (NYSE:MDT) Altaviva device on Friday.

Benzinga

FDA Expands Incyte's Opzelura Approval To Treat Atopic Dermatitis In Children

The U.S. Food and Drug Administration (FDA) on Thursday approved Incyte Corporation’s (NASDAQ:INCY) announced Opzelura (ruxolitinib) cream 1.5% for the short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis (AD) in non-immunocompromised children two years of age and older whose disease is not well controlled with topical prescription…

Barchart

This AI Stock Has More Than Doubled in 2025. Is It a Buy?

After a remarkable triple-digit surge so far in 2025, is now the time to buy the shares of this AI stock?

MarketBeat

Eli Lilly’s Oral GLP-1 Breakthrough Could Change Everything

Eli Lilly stock rises on FDA fast-track hopes for its oral GLP-1 obesity drug and $27B U.S. manufacturing expansion; it's a tough trade but solid long-term hold

Benzinga

Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFs

The U.S. Food and Drug Administration’s recent enforcement action against drug promotion is sending ETFs with exposure to weight-loss treatment manufacturers into question.

The Independent UK

Baby food pouches part of latest food recall due to possible lead contamination

Pouches were sold at Walgreens and independent stores in the U.S. South region

1 … 12 13 14 15

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Trump Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.